← Back to companies
Structure Therapeutics
0 open
South San Francisco, California, United StatesFounded 2016188+ employees$1.8B raisedIPOGPCR
Last round: post ipo equity · $747.5M · Dec 2025(7 rounds total)
Founded by Raymond Stevens
Backed by(21 investors)
Biotechnology Value FundQiming Venture PartnersSage PartnersSurveyor CapitalWoodline PartnersTF CapitalLilly Asia VenturesCasdin CapitalEight Roads VenturesCormorant Asset ManagementTCG CrossoverHSGJanus Henderson Investors
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.
Open Positions at Structure Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Structure Therapeutics?
